psychedelic companies

MAPS Prepares For Trial in Wrongful Death Lawsuit
Can Psychedelics Treat Inflammation and Eye Disease? Eleusis Thinks So.
Psychedelic Pharma’s Big Spin
Numinus’s Acquisition of Novamind May Signal More Consolidation to Come
Hyphae Labs Expands Harm Reduction to Consider Psilocybin 
Will Psychedelic Companies Embrace Indigenous Reciprocity?
Companies Compete to Create DMT Therapies
Compass Releases Framework for Psychedelic-Assisted Therapist Training Program
Field Trip Eyes Washington, D.C. as Former Senator Tom Daschle Joins as an Advisor
An Investor Looks at Drug Development Strategies of Top Psychedelic Companies